# Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)

> **NCT00472953** · PHASE3 · TERMINATED · sponsor: **Novo Nordisk A/S** · enrollment: 38 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** inhaled human insulin
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT00472953
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05-15
- **Primary completion:** 2008-03-05
- **Final completion:** 2008-03-05
- **Target enrollment:** 38 (ACTUAL)
- **Why stopped:** See termination reason in detailed description
- **Last updated:** 2017-03-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00472953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00472953, "Safety of Inhaled Human Insulin in Subjects With Diabetes Mellitus and Chronic Obstructive Pulmonary Disease (COPD)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00472953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*